• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Does Endometrial Scratching Improve IVF Outcomes?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Success of IVF ranges between 25 to 30%/cycle
  • Endometrial scratching
    • Endometrial biopsy (or ‘scratch’) to induce inflammatory reaction
    • Postulated that inflammatory reaction may improve implantation rates by inducing immunologic mechanisms
  • Lensen et al. (N Eng J Med., 2019) sought to determine whether endometrial scratching prior to in vitro fertilization (IVF) increased probability of pregnancy

METHODS:

  • Pragmatic, multicenter, open-label, randomized, controlled trial (RCT)
    • Pipelle for Pregnancy (PIP) trial
  • Participants
    • Women undergoing IVF (fresh and frozen embryo)
    • Protocol determined by local clinical practice
    • No recent exposure to disruptive intrauterine instrumentation
  • Patients received either
    • Endometrial scratching (pipelle) biopsy between day 3 of the cycle preceding the embryo-transfer cycle and day 3 of the IVF cycle
    • No intervention
  • Primary outcome: Live birth
  • Secondary outcomes included
    • Ongoing pregnancy (at 12 weeks) | Clinical pregnancy | Multiple gestation | Ectopic Pregnancy | Biochemical Pregnancy | Miscarriage, Stillbirth and termination | Procedure pain (on a scale of 0 to 10 with higher scores indicating worse pain) | Bleeding post procedure | Maternal and newborn outcomes

RESULTS:

  • 1,364 women were included
  • Frequency of live birth
    • Endometrial-scratch group: 180 of 690 women (26.1%)
    • Control group: 176 of 674 women (26.1%)
    • adjusted odds ratio (OR) 1.00 (95% CI, 0.78 to 1.27)
    • Number of previous failed implantations (≥2 failures) did not alter results
  • There were no significant between-group differences for the following rates
    • Ongoing pregnancy
    • Clinical pregnancy
    • Multiple pregnancy
    • Ectopic pregnancy
    • Miscarriage
  • The median score for pain for endometrial scratching
    • 3.5 (interquartile range, 1.9 to 6.0)
  • Further analysis did not identify any subgroup populations who could potentially benefit from endometrial scratching
  • There were 14 adverse reactions
    • During procedure: Excessive pain (5) | Faint or dizzy (7) | Excessive bleeding (2)
    • No adverse events, including infection, noted post-procedure

CONCLUSION:

  • Authors recognize limitation related to lack of blinding
  • However, results indicate that endometrial scratching does not increase the rate of live births among women undergoing IVF but is associated with mild pain and small rate of adverse events

Learn More – Primary Sources:

A Randomized Trial of Endometrial Scratching before In Vitro Fertilization.

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone

Learn More  »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

ASRM guidance: ART and recommended number of embryos to transfer
Does Acupuncture Help Women Undergoing In Vitro Fertilization Achieve a Live Birth?
POSTAL Study Results: Does Levothyroxine Improve Pregnancy Outcomes in Women with Thyroid Autoantibodies Undergoing IVF?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site